Jasper Therapeutics (JSPR) Restructuring Costs (2020 - 2025)

Jasper Therapeutics has reported Restructuring Costs for 5 years, with the latest figure at $15.8 million in Q2 2025.

• On a quarterly basis, Restructuring Costs rose 154.05% year-over-year to $15.8 million in Q2 2025; TTM through Jun 2025 was $37.8 million, a 185.16% increase from a year earlier, with the FY2024 full-year figure at $34.3 million, down 6.82% from the prior year.
• Restructuring Costs was $15.8 million for Q2 2025 at Jasper Therapeutics, up from $9.8 million in the prior quarter.
• The five-year high for Restructuring Costs was $15.8 million in Q2 2025, with the low at $80000.0 in Q3 2021.
• Average Restructuring Costs over 4 years is $3.6 million, with a median of $480000.0 recorded in 2022.
• The sharpest annual moves came in 2021 and 2022: Restructuring Costs sank 52.94% in 2021, then jumped 493.75% in 2022.
• Over 4 years, Restructuring Costs stood at $99000.0 in 2021, then surged by 379.8% to $475000.0 in 2022, then jumped by 1206.74% to $6.2 million in 2024, then jumped by 154.05% to $15.8 million in 2025.
• The last three Restructuring Costs figures came in at $15.8 million (Q2 2025), $9.8 million (Q1 2025), and $6.2 million (Q2 2024), per Business Quant data.